<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="122" ids="21241">Vitamin C</z:chebi> was shown to be an essential requirement for the growth of mouse <z:mp ids='MP_0009440'>myeloma</z:mp> cells in an in vitro colony assay </plain></SENT>
<SENT sid="1" pm="."><plain>Human <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>) cell colonies grow well in a similar in vitro culture system, and <z:chebi fb="122" ids="21241">vitamin C</z:chebi> has been shown to enhance the growth of leukemic cell colonies in 77 (35%) of 219 leukemic patients while none of 34 <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrows tested simultaneously shows growth enhancement by this vitamin </plain></SENT>
<SENT sid="2" pm="."><plain>This <z:chebi fb="122" ids="21241">vitamin C</z:chebi> effect is reproducible in repeated experiments in same patients, specific to this vitamin, selective for leukemic cells, and is proven to be biological in nature </plain></SENT>
<SENT sid="3" pm="."><plain>Further, leukemic cells are mobilized back and forth between cycling and resting states with <z:chebi fb="122" ids="21241">vitamin C</z:chebi> supplementation/<z:mpath ids='MPATH_63'>depletion</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Our more recent study indicates that the <z:e sem="disease" ids="C0026986,C0033027" disease_type="Neoplastic Process" abbrv="">preleukemia</z:e> (<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>), generally known to be related to <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, has similar pattern in terms of <z:chebi fb="122" ids="21241">vitamin C</z:chebi> sensitivity, with 8 of 25 patients (32%) showing the growth enhancement with this vitamin </plain></SENT>
</text></document>